longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SPDR Pharmac

XPH

----
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI
  • Weekly Recap | Editas Medicine -16.41%, consensus target above spot

    Weekly Review·2 days ago, 08:10 AM
    EDIT+1.48%
  • Weekly Recap | DFTX.US +2.1%, consensus target above spot

    Weekly Review·2 days ago, 08:05 AM
    DFTX+3.50%
  • Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buy

    Weekly Review·2 days ago, 07:49 AM
    CAI+7.03%
  • Weekly Recap | Abbvie +0.26%, most brokers rate it buy

    Weekly Review·2 days ago, 07:40 AM
    ABBV+1.81%
  • Weekly Recap | Twist Bioscience +2%, consensus target below spot

    Weekly Review·2 days ago, 07:00 AM
    TWST+5.92%
  • Weekly Recap | Nuvation Bio -10.87%, consensus target above spot

    Weekly Review·2 days ago, 06:29 AM
    NUVB-2.14%
  • Weekly Recap | Nuvation Bio +2.25%, most brokers rate it buy

    Weekly Review·Sep 5 at 07:34 AM
    NUVB-2.14%
  • Weekly Recap | Corcept Therap -1.98%, most brokers rate it buy

    Weekly Review·Sep 5 at 06:29 AM
    CORT-0.88%
  • Weekly Recap | AMLX.US +78.73%, Phase 3 win sparks rally

    Weekly Review·Aug 22 at 06:56 AM
    AMLX+6.39%